Drug Shortage Report for MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL
Report ID | 23172 |
Drug Identification Number | 02443902 |
Brand name | MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL |
Common or Proper name | EMTRICITABINE/TENOFOVIR DISOPROXIL |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE |
Strength(s) | 300MG 200MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30BT |
ATC code | J05AR |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-12-19 |
Actual start date | |
Estimated end date | 2019-01-11 |
Actual end date | 2018-12-18 |
Shortage status | Avoided shortage |
Updated date | 2018-12-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-09-22 | English | Compare |
v2 | 2017-09-22 | French | Compare |
v3 | 2017-09-28 | English | Compare |
v4 | 2017-09-28 | French | Compare |
v5 | 2017-10-05 | English | Compare |
v6 | 2017-10-05 | French | Compare |
v7 | 2017-10-13 | English | Compare |
v8 | 2017-10-13 | French | Compare |
v9 | 2017-10-18 | English | Compare |
v10 | 2017-10-19 | English | Compare |
v11 | 2017-10-19 | French | Compare |
v12 | 2017-11-27 | English | Compare |
v13 | 2017-11-27 | French | Compare |
v14 | 2017-11-29 | English | Compare |
v15 | 2017-11-29 | French | Compare |
v16 | 2017-11-30 | English | Compare |
v17 | 2017-11-30 | French | Compare |
v18 | 2017-12-01 | English | Compare |
v19 | 2017-12-01 | French | Compare |
v20 | 2017-12-04 | English | Compare |